This week’s bulletin is much shorter than usual, largely owing to the fact that we published the second section of our Psychedelics 2021: A Year in Review series this week. Scroll down to the Weekend Reads segment to read the blurb and access the report on Psychedelic Research and Clinical Trials in 2021. Shortly after we sent our bulletin last Friday, MindMed announced the resignation of co…


Previous articlePharmaDrug Announces Resignation of Director
Next articleFilament Health and Cybin Therapeutics Announce Licensing Agreement